Hautarztpraxis Mortazawi GbR
- Address
- Schwelmer Strasse 25, 42897 Remscheid, Germany
Immune System Diseases
At Hautarztpraxis Mortazawi GbR, researchers are investigating immune system diseases with a focus on active psoriatic arthritis. The trial aims to evaluate the effectiveness and safety of a novel therapy compared with placebo.
- Active Psoriatic Arthritis
- JNJ-88545223 efficacy evaluation
- Placebo‑controlled assessment
Findings will help determine whether the new treatment can improve joint symptoms and overall quality of life for patients.
Skin and Connective Tissue Diseases
The practice also conducts research on skin and connective tissue diseases, specifically moderate to severe plaque psoriasis. The objective is to assess long‑term safety and tolerability of an investigational medication.
- Plaque Psoriasis
- ESK-001 safety study
- Durability of response evaluation
Results could broaden therapeutic options for individuals dealing with persistent and extensive skin lesions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Janssen Cilag International1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautarztpraxis Mortazawi GbR
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-88545223 in Participants with Active Psoriatic Arthritis | Janssen Cilag International | Phase II | Recruiting | Mar 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Envudeucitinib | 1 | Unknown | 2025-06-13 | 2025-06-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.